Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HEMOPHILIA B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Early research (Phase 1)Not Yet RecruitingNCT03961243
What this trial is testing

Lentiviral FIX Gene Therapy

Who this might be right for
Hemophilia B
Shenzhen Geno-Immune Medical Institute 10
Large-scale testing (Phase 3)Study completedNCT00866606
What this trial is testing

Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 35
Testing effectiveness (Phase 2)Looking for participantsNCT06120582
What this trial is testing

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Who this might be right for
Hemophilia B
Biocad 28
Not applicableUnknownNCT03946384
What this trial is testing

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype

Who this might be right for
Hemophilia B
Centre Hospitalier Universitaire Dijon 12
Early research (Phase 1)Study completedNCT02213250
What this trial is testing

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 12
Not applicableNot Yet RecruitingNCT07736976
What this trial is testing

Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy Peers

Who this might be right for
Hemophilia A and B
Bahçeşehir University 58
Large-scale testing (Phase 3)Study completedNCT02234310
What this trial is testing

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

Who this might be right for
Hemophilia B
Bioverativ, a Sanofi company 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05203679
What this trial is testing

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Who this might be right for
Hemophilia B
Shanghai Xinzhi BioMed Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Testing effectiveness (Phase 2)Looking for participantsNCT05641610
What this trial is testing

Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 21
Large-scale testing (Phase 3)Ended earlyNCT02484638
What this trial is testing

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
CSL Behring 25
Testing effectiveness (Phase 2)Study completedNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Very early researchStudy completedNCT03272568
What this trial is testing

Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers

Who this might be right for
HemophiliaMenstrual Flow Excessive
Emory University 3
Not applicableStudy completedNCT04731701
What this trial is testing

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 180
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Not applicableStudy completedNCT01579955
What this trial is testing

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 321
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Not applicableActive Not RecruitingNCT07161687
What this trial is testing

Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

Who this might be right for
Hemophilia A or B
Pfizer 50
Next Page